{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:13:07Z","timestamp":1790485987013,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["journal-of-hepatology.eu","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.jhep.2014.04.038","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T00:45:17Z","timestamp":1399250717000},"page":"502-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":152,"title":["Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus"],"prefix":"10.1016","volume":"61","author":[{"given":"Astrid-Jane","family":"Greenup","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pok Kern","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vi","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ushmi","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Holdaway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dev","family":"Samarasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Locarnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam T.","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.04.038_b0005","unstructured":"WHO. Hepatitis B. World Health Organisation Fact Sheet; 2012, http:\/\/www.who.int\/mediacentre\/factsheets\/fs204\/en."},{"key":"10.1016\/j.jhep.2014.04.038_b0010","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.cld.2007.08.004","article-title":"Hepatitis B in pregnancy","volume":"11","author":"Gambarin-Gelwan","year":"2007","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jhep.2014.04.038_b0015","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1056\/NEJM200205303462202","article-title":"Chronic hepatitis B","volume":"346","author":"Lok","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2014.04.038_b0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jmv.1890220102","article-title":"Age- and sex-related study of hepatitis B virus chronic carrier state in infants from an endemic area (Senegal)","volume":"22","author":"Coursaget","year":"1987","journal-title":"J Med Virol"},{"key":"10.1016\/j.jhep.2014.04.038_b0025","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/infdis\/146.2.198","article-title":"Incidence of hepatitis B virus infections in preschool children in Taiwan","volume":"146","author":"Beasley","year":"1982","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.04.038_b0030","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/151.4.599","article-title":"Acute hepatitis B virus infection: relation of age to the clinical expression of disease and subsequent development of the carrier state","volume":"151","author":"McMahon","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jhep.2014.04.038_b0035","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/0016-5085(87)90614-7","article-title":"Natural history of acute hepatitis B surface antigen-positive hepatitis in Greek adults","volume":"92","author":"Tassopoulos","year":"1987","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.038_b0040","doi-asserted-by":"crossref","first-page":"E16","DOI":"10.1046\/j.1440-1746.2000.02096.x","article-title":"Natural history of hepatitis B virus infection in children","volume":"15","author":"Chang","year":"2000","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.038_b0045","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/S0140-6736(83)90624-4","article-title":"Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine","volume":"2","author":"Beasley","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.04.038_b0050","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1136\/bmj.38719.435833.7C","article-title":"Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis","volume":"332","author":"Lee","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/j.jhep.2014.04.038_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/hep.25988","article-title":"Chronic hepatitis B infection in adolescents who received primary infantile vaccination","volume":"57","author":"Wu","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.038_b0060","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/j.1365-2893.2011.01492.x","article-title":"Virologic factors associated with failure to passive-active immunoprophylaxis in infants born to HBsAg-positive mothers","volume":"19","author":"Zou","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.04.038_b0065","doi-asserted-by":"crossref","first-page":"489","DOI":"10.5694\/j.1326-5377.2009.tb02524.x","article-title":"Perinatal transmission of hepatitis B virus: an Australian experience","volume":"190","author":"Wiseman","year":"2009","journal-title":"Med J Aust"},{"key":"10.1016\/j.jhep.2014.04.038_b0070","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1046\/j.1365-2893.2003.00440.x","article-title":"Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection","volume":"10","author":"van Zonneveld","year":"2003","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.04.038_b0075","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11901-012-0130-x","article-title":"Optimal management of the hepatitis B patient who desires pregnancy or is pregnant","volume":"11","author":"Bzowej","year":"2012","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.jhep.2014.04.038_b0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/AOG.0b013e3181e45951","article-title":"Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis","volume":"116","author":"Shi","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.jhep.2014.04.038_b0085","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejogrb.2013.02.001","article-title":"Towards complete eradication of hepatitis B infection from perinatal transmission: review of the mechanisms of in utero infection and the use of antiviral treatment during pregnancy","volume":"169","author":"Cheung","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.jhep.2014.04.038_b0090","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/liv.12060","article-title":"Optimal management of HBV infection during pregnancy","volume":"33","author":"Piratvisuth","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2014.04.038_b0095","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1016\/j.ajog.2012.06.001","article-title":"Antenatal lamivudine to reduce perinatal hepatitis B transmission: a cost-effectiveness analysis","volume":"207","author":"Nayeri","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.jhep.2014.04.038_b0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1743-422X-9-185","article-title":"The effects of telbivudine in late pregnancy to prevent intrauterine transmission of the hepatitis B virus: a systematic review and meta-analysis","volume":"9","author":"Deng","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.jhep.2014.04.038_b0105","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1365-2893.2008.01056.x","article-title":"Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study","volume":"16","author":"Xu","year":"2009","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.04.038_b0110","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11901-012-0144-4","article-title":"Preventing perinatal transmission of HBV: an Australian perspective","volume":"11","author":"Levy","year":"2012","journal-title":"Curr Hepat Rep"},{"key":"10.1016\/j.jhep.2014.04.038_b0115","first-page":"157","article-title":"Efficacy and safety of telbivudine in preventing mother-to-infant HBV transmission","volume":"2010","author":"Zhang","year":"2010","journal-title":"Adverse Drug React J"},{"key":"10.1016\/j.jhep.2014.04.038_b0120","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.jhep.2011.02.032","article-title":"A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection","volume":"55","author":"Han","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.038_b0125","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.cgh.2012.01.019","article-title":"Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B","volume":"10","author":"Pan","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2014.04.038_b0130","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1053\/jhep.2000.19622","article-title":"Evolution of hepatitis B virus polymerase gene mutations in hepatitis B e antigen-negative patients receiving lamivudine therapy","volume":"32","author":"Lok","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.038_b0135","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/jhep.2002.33894","article-title":"Course of virologic breakthroughs under long-term lamivudine in HBeAg-negative precore mutant HBV liver disease","volume":"36","author":"Papatheodoridis","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2014.04.038_b0140","doi-asserted-by":"crossref","first-page":"e1591","DOI":"10.1053\/j.gastro.2009.08.063","article-title":"Hepatitis B virus resistance to nucleos(t)ide analogues","volume":"137","author":"Zoulim","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.038_b0145","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/j.gastro.2008.10.026","article-title":"2-Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B","volume":"136","author":"Liaw","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2014.04.038_b0150","article-title":"Short duration of lamivudine for prevention of HBV transmission in pregnancy: lack of potency and selection of resistance mutations","author":"Ayres","year":"2013","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.jhep.2014.04.038_b0155","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jhep.2008.01.027","article-title":"Impact of hepatitis B virus rtA181V\/T mutants on hepatitis B treatment failure","volume":"48","author":"Villet","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.038_b0160","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.jhep.2012.06.031","article-title":"Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the antiretroviral pregnancy registry","volume":"57","author":"Brown","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.038_b0165","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/AAC.00350-08","article-title":"Chronic administration of tenofovir to rhesus macaques from infancy through adulthood and pregnancy: summary of pharmacokinetics and biological and virological effects","volume":"52","author":"Van Rompay","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2014.04.038_b0170","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1097\/QAD.0b013e328352d135","article-title":"Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants","volume":"26","author":"Siberry","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.04.038_b0175","doi-asserted-by":"crossref","first-page":"e1001217","DOI":"10.1371\/journal.pmed.1001217","article-title":"Pregnancy and infant outcomes among HIV-infected women taking long-term ART with and without tenofovir in the DART trial","volume":"9","author":"Gibb","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.jhep.2014.04.038_b0180","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s10620-012-2187-3","article-title":"Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viraemic pregnant women: a case series","volume":"57","author":"Pan","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2014.04.038_b0185","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1111\/apt.12726","article-title":"Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare","volume":"39","author":"Nguyen","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2014.04.038_b0190","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1440-1754.1996.tb00965.x","article-title":"New South Wales population-based birthweight percentile charts","volume":"32","author":"Beeby","year":"1996","journal-title":"J Paediatr Child Health"},{"issue":"5","key":"10.1016\/j.jhep.2014.04.038_b0195","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/0009922813510600","article-title":"Timing of head circumference measurement in newborns","volume":"53","author":"Simic Klaric","year":"2014","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.jhep.2014.04.038_b0200","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1128\/AAC.00514-10","article-title":"Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d\u2019Ivoire, in the ANRS 12109 TEmAA Study, Step 2","volume":"55","author":"Benaboud","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jhep.2014.04.038_b0205","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3748\/wjg.v9.i7.1501","article-title":"Interruption of HBV intrauterine transmission: a clinical study","volume":"9","author":"Li","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jhep.2014.04.038_b0210","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1592\/phco.23.1.29.31915","article-title":"Tenofovir: a nucleotide analog for the management of human immunodeficiency virus infection","volume":"23","author":"Antoniou","year":"2003","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jhep.2014.04.038_b0215","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1177\/1756283X09354562","article-title":"Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B","volume":"3","author":"Duarte-Rojo","year":"2010","journal-title":"Ther Adv Gastroenterol"},{"issue":"1","key":"10.1016\/j.jhep.2014.04.038_b0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s13181-013-0325-8","article-title":"A review of the toxicity of HIV medications","volume":"10","author":"Margolis","year":"2014","journal-title":"J Med Toxicol"},{"key":"10.1016\/j.jhep.2014.04.038_b0225","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/QAD.0b013e3282f08cdc","article-title":"Risk factors for lactic acidosis and severe hyperlactataemia in HIV-1-infected adults exposed to antiretroviral therapy","volume":"21","author":"Lactic Acidosis International Study Group","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.jhep.2014.04.038_b0230","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000338659","article-title":"Idiopathic polyhydramnios and postnatal abnormalities","volume":"32","author":"Abele","year":"2012","journal-title":"Fetal Diagn Ther"},{"key":"10.1016\/j.jhep.2014.04.038_b0235","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.04.038_b0240","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2471\/BLT.08.062554","article-title":"The worldwide incidence of preterm birth: a systematic review of maternal mortality and morbidity","volume":"88","author":"Beck","year":"2010","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.jhep.2014.04.038_b0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00404-003-0525-6","article-title":"Perinatal outcome associated with oligohydramnios in uncomplicated term pregnancies","volume":"269","author":"Locatelli","year":"2004","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.jhep.2014.04.038_b0250","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bpobgyn.2008.08.004","article-title":"Epidemiology of postpartum haemorrhage: a systematic review","volume":"22","author":"Carroli","year":"2008","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.jhep.2014.04.038_b0255","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2005.05.023","article-title":"The impact of maternal HBsAg carrier status on pregnancy outcomes: a case-control study","volume":"43","author":"Tse","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.038_b0260","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(99)07219-0","article-title":"Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues","volume":"354","author":"Blanche","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.04.038_b0265","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00126334-200011010-00009","article-title":"Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5years of age in five United States cohorts","volume":"25","year":"2000","journal-title":"J Acquir Immune Defic Syndr"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2015.07.017","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814003018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814003018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T20:38:02Z","timestamp":1597783082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814003018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0168827814003018"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.04.038","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.jhep.2015.07.017","asserted-by":"object"}]},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.04.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}